Walter W Shuford

Title: Walter W. Shuford: Innovator in Humanized Antibodies

Introduction

Walter W. Shuford is a notable inventor based in Redmond, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 3 patents to his name, Shuford's work has the potential to impact cancer treatment significantly.

Latest Patents

Shuford's latest patents include innovative approaches to humanized antibodies targeting human 4-1BB. One of his patents describes a humanized antibody that binds to human 4-1BB, facilitating its interaction with the human 4-1BB ligand. This antibody is characterized as an IgG4 antibody. Additionally, he has developed a method for treating cancer by administering a therapeutically effective amount of this antibody to a subject. Another patent focuses on similar humanized antibodies against human 4-1BB, emphasizing their therapeutic potential in oncology.

Career Highlights

Walter W. Shuford is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research in antibody development. His work is crucial in the ongoing efforts to create effective cancer therapies.

Collaborations

Shuford collaborates with esteemed colleagues, including Robert S. Mittler and Maria Jure Kunkel. Their combined expertise enhances the innovative research environment at Bristol-Myers Squibb.

Conclusion

Walter W. Shuford's contributions to the field of biotechnology, particularly in the development of humanized antibodies, showcase his commitment to advancing cancer treatment. His innovative patents and collaborations position him as a key figure in the ongoing battle against cancer.